湘佳股份(002982) - 2021 Q1 - 季度财报

Revenue and Profit - Revenue for Q1 2021 reached ¥725,544,696.29, an increase of 36.57% compared to ¥531,252,977.96 in the same period last year[7] - Net profit attributable to shareholders was ¥8,183,334.42, a decrease of 92.46% from ¥108,470,338.35 year-on-year[7] - Net profit excluding non-recurring gains and losses was ¥5,329,026.86, down 95.08% from ¥108,404,027.46 in the previous year[7] - Basic earnings per share decreased by 94.37% to ¥0.08 from ¥1.42 in the previous year[7] - Net profit for Q1 2021 was ¥7,482,198.29, a decrease from ¥107,603,222.45 in the previous year[42] - The total profit for the period was ¥8,354,675.24, down from ¥108,771,988.30 in the same period last year[42] - Basic and diluted earnings per share were both CNY 0.14, down from CNY 1.54 in the previous period[47] Cash Flow - Operating cash flow for the period was ¥6,201,461.80, a decline of 51.11% compared to ¥12,685,472.35 in the same quarter last year[7] - Cash inflow from operating activities was CNY 777,712,433.04, an increase from CNY 482,338,389.52 in the previous period[49] - Cash outflow from operating activities totaled CNY 771,510,971.24, compared to CNY 469,652,917.17 in the previous period[50] - Net cash flow from operating activities was CNY 6,201,461.80, down from CNY 12,685,472.35 in the previous period[50] - Net cash flow from investing activities was -CNY 120,112,751.62, compared to -CNY 32,953,537.90 in the previous period[50] - Net cash flow from financing activities was -CNY 18,916,823.29, a decrease from CNY 56,338,906.91 in the previous period[51] - The ending balance of cash and cash equivalents was CNY 529,629,492.24, down from CNY 228,013,817.78 in the previous period[51] - The company reported a net decrease in cash and cash equivalents of CNY 132,828,113.11 for the period[51] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,466,300,789.95, reflecting a 3.73% increase from ¥2,377,630,161.37 at the end of the previous year[7] - Total current assets decreased from CNY 1,186,845,584.73 to CNY 1,059,241,715.74, a decline of approximately 10.74%[32] - Total non-current assets increased from CNY 1,190,784,576.64 to CNY 1,407,059,074.21, a growth of about 18.19%[33] - Total current liabilities increased from CNY 568,500,519.17 to CNY 621,848,990.87, a rise of about 9.36%[34] - Total liabilities increased from CNY 744,082,400.82 to CNY 804,966,335.81, an increase of approximately 8.19%[34] - Owner's equity totaled ¥1,597,121,167.89, up from ¥1,583,171,897.07 in the previous period, showing growth in shareholder value[41] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,543[11] - Major shareholders include Yu Ziwen and Xing Weimin, each holding 22.58% of shares[11] Research and Development - R&D expenses surged by 843.86% to ¥4,000,131.69, reflecting increased investment in feed nutrition and poultry breeding research[16] - Research and development expenses increased to ¥4,000,131.69 from ¥423,805.96, highlighting a focus on innovation[41] Other Financial Metrics - The company reported non-recurring gains totaling ¥2,854,307.56, including government subsidies of ¥2,952,254.47[8] - Other income rose by 261.28% to ¥2,952,254.47, mainly due to the continuation of social security policy reductions[16] - Management expenses increased by 91.66% to ¥19,876,683.63, driven by higher labor costs and depreciation[16] - The company reported a credit impairment loss of ¥1,884,541.43, a significant improvement from a loss of ¥-3,269,131.40 in the previous year[41] Investment Activities - Investment cash flow net amount dropped by 264.49% to -¥120,112,751.62 due to increased fixed asset project investments[16] - The company plans to issue convertible bonds, with approval from the China Securities Regulatory Commission received on March 11, 2021[17] - Total funds raised from the public offering of shares amounted to ¥759,416,900, with a net amount of ¥645,635,700 after expenses[22] - The company has utilized ¥190,073,100 of the raised funds, with a remaining balance of ¥270,577,000[22] Inventory and Receivables - Accounts receivable decreased from CNY 185,299,246.57 to CNY 153,494,410.83, a reduction of about 17.14%[32] - Inventory increased from CNY 281,878,867.89 to CNY 300,431,353.57, an increase of approximately 6.06%[32] - Prepayments increased by 110.69% to ¥29,602,054.21 due to higher advance payments for raw material auctions[16] - Biological assets rose by 122.83% to ¥61,547,233.38 primarily from the acquisition of Hunan Sanjian Animal Husbandry Co., Ltd.[16]